Involvement of the Akt/NF-κB pathways in the HTNV-mediated increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yu, Haitao ^a   Jiang, Wei ^a   Du, Hong ^a   Xing, Yuan ^b   Bai, Guangzhen ^a   Zhang, Ye ^a   Li, Yu ^c   Jiang, Hong ^a   Zhang, Ying ^a   Wang, Jiuping ^a   Wang, Pingzhong ^a   Bai, Xuefan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARDAMONIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PROTEIN KINASE B; RANTES; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CHALCONE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME INHIBITION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

CHALCONES; CHEMOKINE CCL5; HANTAAN VIRUS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84899531922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093810     Document Type: Article

References (58)

1. Kariwa H, Yoshimatsu K, Arikawa J (2007) Hantavirus infection in East Asia. Comp Immunol Microbiol Infect Dis 30: 341-356. (Pubitemid 47450088)
2. Kitamura T, Morita C, Komatsu T, Sugiyama K, Arikawa J, et al. (1983) Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system. Jpn J Med Sci Biol 36: 17-25. (Pubitemid 13082817)
3. Schmaljohn CS, Hasty SE, Dalrymple JM, LeDuc JW, Lee HW, et al. (1985) Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227: 1041-1044. (Pubitemid 15142044)
4. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, et al. (1993) Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262: 914-917. (Pubitemid 24014083)
5. Zhang Y, Li XH, Jiang H, Huang CX, Wang PZ, et al. (2008) Expression of L protein of Hantaan virus 84FLi strain and its application for recovery of minigenomes. APMIS 116: 1089-1096.
6. Cosgriff TM (1991) Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 13: 97-107.
7. Hayasaka D, Maeda K, Ennis FA, Terajima M (2007) Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res 123: 120-127. (Pubitemid 46054332)
8. Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER (2008) Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 82: 5797-5806. (Pubitemid 351822254)
9. Niikura M, Maeda A, Ikegami T, Saijo M, Kurane I, et al. (2004) Modification of endothelial cell functions by Hantaan virus infection: prolonged hyperpermeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers. Arch Virol 149: 1279-1292. (Pubitemid 38927633)
10. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, et al. (1995) Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146: 552-579.
11. Saksida A, Wraber B, Avsic-Zupanc T (2011) Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis 11: 142.
12. Wang PZ, Li ZD, Yu HT, Zhang Y, Wang W, et al. (2012) Elevated serum concentrations of inflammatory cytokines and chemokines in patients with haemorrhagic fever with renal syndrome. J Int Med Res 40: 648-656.
13. Sundstrom JB, McMullan LK, Spiropoulou CF, Hooper WC, Ansari AA, et al. (2001) Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 75: 6070-6085. (Pubitemid 32553138)
14. Macneil A, Nichol ST, Spiropoulou CF (2011) Hantavirus pulmonary syndrome. Virus Res 162: 138-147.
15. Lyck R, Reiss Y, Gerwin N, Greenwood J, Adamson P, et al. (2003) T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood 102: 3675-3683. (Pubitemid 37409388)
16. Qi BT, Wang P, Li J, Ren HX, Xie M (2006) Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-2 in plasma of patients with hemorrhagic fever with renal syndrome, and significance of the changes in level. Viral Immunol 19: 565-569. (Pubitemid 44735068)
17. Han Q, Zhang L, Liu Z, Kang W, Lou S, et al. (2010) Elevated sICAM-1 levels in patients with hemorrhagic fever with renal syndrome caused by Hantaan virus. Eur J Clin Microbiol Infect Dis 29: 1507-1511.
18. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
19. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
20. Santoro MG, Rossi A, Amici C (2003) NF-kappaB and virus infection: who controls whom. EMBO J 22: 2552-2560. (Pubitemid 36712353)
21. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288. (Pubitemid 38610351)
22. Madrid LV, Mayo MW, Reuther JY, Baldwin AS, (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940.
23. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, et al. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20: 1626-1638. (Pubitemid 30100182)
24. Kim YJ, Ko H, Park JS, Han IH, Amor EC, et al. (2010) Dimethyl cardamonin inhibits lipopolysaccharide-induced inflammatory factors through blocking NF-kappaB p65 activation. Int Immunopharmacol 10: 1127-1134.
25. Lee JH, Jung HS, Giang PM, Jin X, Lee S, et al. (2006) Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. J Pharmacol Exp Ther 316: 271-278. (Pubitemid 41832606)
26. Sheikh AM, Ochi H, Manabe A, Masuda J (2005) Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells. Cardiovasc Res 65: 263-271. (Pubitemid 40038500)
27. Lee HW, Lee PW, Johnson KM (1978) Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis 137: 298-308. (Pubitemid 8309146)
28. Vapalahti O, Lundkvist A, Kukkonen SK, Cheng Y, Gilljam M, et al. (1996) Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol 77 (Pt 12): 3063-3067. (Pubitemid 27056526)
29. Xu Z, Huang CX, Li Y, Wang PZ, Ren GL, et al. (2007) Toll-like receptor 4 siRNA attenuates LPS-induced secretion of inflammatory cytokines and chemokines by macrophages. J Infect 55: e1-9. (Pubitemid 46888072)
30. Ren GL, Bai XF, Zhang Y, Chen HM, Huang CX, et al. (2005) Stable inhibition of hepatitis B virus expression and replication by expressed siRNA. Biochem Biophys Res Commun 335: 1051-1059. (Pubitemid 41215525)
31. Yu HT, Jiang H, Zhang Y, Nan XP, Li Y, et al. (2012) Hantaan virus triggers TLR4-dependent innate immune responses. Viral Immunol 25: 387-393.
32. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
33. Bernasconi D, Amici C, La Frazia S, Ianaro A, Santoro MG (2005) The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells. J Biol Chem 280: 24127-24134. (Pubitemid 40884900)
34. Amici C, Belardo G, Rossi A, Santoro MG (2001) Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy. J Biol Chem 276: 28759-28766.
35. Nabel G, Baltimore D (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713. (Pubitemid 17059793)
36. Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G (2007) Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell Microbiol 9: 2040-2054. (Pubitemid 47087094)
37. Gustems M, Borst E, Benedict CA, Perez C, Messerle M, et al. (2006) Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer. J Virol 80: 9899-9904. (Pubitemid 44435665)
38. Benedict CA, Angulo A, Patterson G, Ha S, Huang H, et al. (2004) Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol 78: 741-750. (Pubitemid 38067596)
39. Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A 98: 10983-10985. (Pubitemid 32928669)
40. Toker A, Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387: 673-676. (Pubitemid 27270600)
41. Mayo LD, Donner DB (2001) A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci U S A 98: 11598-11603. (Pubitemid 32928774)
42. Ashcroft M, Ludwig RL, Woods DB, Copeland TD, Weber HO, et al. (2002) Phosphorylation of HDM2 by Akt. Oncogene 21: 1955-1962. (Pubitemid 34270884)
43. Kane LP, Mollenauer MN, Xu Z, Turck CW, Weiss A (2002) Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol Cell Biol 22: 5962-5974. (Pubitemid 34815843)
44. Nakabayashi H, Shimizu K (2012) Involvement of Akt/NF-kappaB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo. BMC Cancer 12: 453.
45. Shah A, Silverstein PS, Singh DP, Kumar A (2012) Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-kappaB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. J Neuroinflammation 9: 52.
46. Sen T, Sen N, Noordhuis MG, Ravi R, Wu TC, et al. (2012) OGDHL is a modifier of AKT-dependent signaling and NF-kappaB function. PLoS One 7: e48770.
47. Balwani S, Chaudhuri R, Nandi D, Jaisankar P, Agrawal A, et al. (2012) Regulation of NF-kappaB activation through a novel PI-3K-independent and PKA/Akt-dependent pathway in human umbilical vein endothelial cells. PLoS One 7: e46528.
48. Dai C, Zheng CQ, Meng FJ, Zhou Z, Sang LX, et al. (2013) VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-kappaB pathway in rat model of DSS-induced colitis. Mol Cell Biochem 374: 1-11.
49. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, et al. (2004) Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 279: 1615-1620. (Pubitemid 38084426)
50. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, et al. (2002) Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 99: 13837-13842. (Pubitemid 35215467)
51. Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, et al. (1995) Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 26: 110-120.
52. Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, et al. (1999) High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 179: 295-302. (Pubitemid 29086629)
53. Kanerva M, Mustonen J, Vaheri A (1998) Pathogenesis of puumala and other hantavirus infections. Rev Med Virol 8: 67-86. (Pubitemid 28288156)
54. Sadeghi M, Eckerle I, Daniel V, Burkhardt U, Opelz G, et al. (2011) Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol 12: 65.
55. Outinen TK, Makela SM, Ala-Houhala IO, Huhtala HS, Hurme M, et al. (2010) The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis 10: 132.
56. Jiang H, Wang PZ, Zhang Y, Xu Z, Sun L, et al. (2008) Hantaan virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon, interleukin-6 and tumor necrosis factor-alpha. Virology 380: 52-59.
57. Shah A, Silverstein PS, Kumar S, Singh DP, Kumar A (2012) Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes. PLoS One 7: e52060.
58. Tsoyi K, Jang HJ, Nizamutdinova IT, Park K, Kim YM, et al. (2010) PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3beta/GATA-6 signaling pathways in TNF-alpha-activated human endothelial cells. Atherosclerosis 213: 115-121.